Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04656548 · ClinicalTrials.gov registry record
A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line
A clinical trial, sponsored by Access Vascular.
- Completed
- Registry status
- 121
- Enrollment target
NCT04656548: Completed study, sponsored by Access Vascular.
NCT04656548 is a clinical trial that has completed, run by Access Vascular. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04656548 has completed, sponsored by Access Vascular.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
Primary Outcome
Comparison of actual vs intended dwell times of each arm
Interventions
- DEVICE HydroPICC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-04-23 |
What the finished NCT04656548 record still lists
NCT04656548 is an observational study that tracks outcomes without assigning an intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which HydroPICC is the first listed.
NCT04656548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04656548 about?
NCT04656548 is a clinical study titled "A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line". This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
What is the current status of trial NCT04656548?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2020-11-13. Estimated completion is 2021-04-23.
What interventions are being tested in trial NCT04656548?
The interventions under investigation include: HydroPICC (DEVICE).
Who is sponsoring clinical trial NCT04656548?
This trial is sponsored by Access Vascular, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI